Premium
Response to direct‐acting antivirals for hepatitis C treatment in vertically HIV/HCV co‐infected patients
Author(s) -
Carrasco Itzíar,
Sainz Talía,
Frick Marie Antoinette,
Jiménez de Ory Santiago,
Fortuny Claudia,
Burgos Joaquin,
Montero Marta,
Gavilán César,
Falcón María Dolores,
Couceiro José Antonio,
Bernardino José Ignacio,
Bisbal Otilia,
Guerrero Carmelo,
AldámizEchevarría María Teresa,
Berenguer Juan,
Navarro María Luisa
Publication year - 2020
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/jvh.13308
Subject(s) - medicine , human immunodeficiency virus (hiv) , hepatitis c , transmission (telecommunications) , cohort , hepatitis c virus , virology , virus , electrical engineering , engineering
Direct‐acting antivirals (DAAs) for HCV treatment have improved tolerance and efficacy among adults, but experience in vertical transmission is scarce. In our vertically HIV/HCV co‐infected youth cohort of 58 patients, DAA achieved excellent rates of cure among naïve and pretreated individuals. Treating vertically infected seems important as 29.6% displayed advanced fibrosis at treatment initiation.